antineoplastics
455 results
301 - 400
everolimus- pertuzumab
- blinatumomab
- nivolumab
- pembrolizumab
- ado-trastuzumab
- alectinib
- osimertinib
- trifluridine/tipiracil
- ramucirumab
- cemiplimab
- decitabine/cedazuridine
- infigratinib
- dostarlimab
- loncastuximab tesirine
- olutasidenib
- amifostine
- arsenic trioxide
- DAUNOrubicin hydrochloride
- megestrol
- mercaptopurine
- DOXOrubicin, liposomal
- ipilimumab
- irinotecan liposomal
- durvalumab
- avapritinib
- erdafitinib
- pemigatinib
- tisotumab vedotin
- mobocertinib
- belzutifan
- futibatinib
- sirolimus (protein bound)
- tremelimumab
- PACLitaxel
- riTUXimab
- trastuzumab
- testosterone enanthate
- tositumomab (I 131 tositumomab)
- lycopene
- atezolizumab
- daunorubicin/cytarabine liposomal
- inotuzumab ozogamicin
- daratumumab/hyaluronidase
- amivantamab
- azaTHIOprine
- filgrastim
- gemtuzumab ozogamicin
- lutetium lu 177 dotatate
- fam-trastuzumab deruxtecan
- altretamine
- leuprolide
- methotrexate
- teniposide
- levamisole
- rituximab/hyaluronidase
- trastuzumab/hyaluronidase
- lutetium lu-177 vipivotide tetraxetan
- cladribine
- bevacizumab
- INTERFERONS, ALPHA
- diethylstilbestrol
- nelarabine
- carmustine
- pentamidine
- interferon alpha-2b
- pertuzumab/trastuzumab/hyaluronidase
- antiemetics
- epiRUBicin
- vinBLAStine
- ibrutinib
- DAUNOrubicin citrate liposome
- flucytosine
- ifosfamide
- lomustine
- alatrofloxacin
- bendamustine
- tofacitinib
- bosutinib
- cyproterone
- etrasimod
- corticosteroids
- AMPHOTERICIN B
- cycloPHOSphamide
- medroxyPROGESTERone†
- nabumetone
- sulfinpyrazone
- lomefloxacin
- fingolimod
- buserelin
- busulfan
- fludarabine
- thiotepa
- plicamycin
- enzalutamide
- capecitabine
- topotecan